0001209191-17-007742.txt : 20170203 0001209191-17-007742.hdr.sgml : 20170203 20170203172245 ACCESSION NUMBER: 0001209191-17-007742 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170201 FILED AS OF DATE: 20170203 DATE AS OF CHANGE: 20170203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RXi Pharmaceuticals Corp CENTRAL INDEX KEY: 0001533040 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 257 SIMARANO DRIVE STREET 2: SUITE 101 CITY: MARLBOROUGH STATE: MA ZIP: 01752 BUSINESS PHONE: (508) 767-3861 MAIL ADDRESS: STREET 1: 257 SIMARANO DRIVE STREET 2: SUITE 101 CITY: MARLBOROUGH STATE: MA ZIP: 01752 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dorman H. Paul CENTRAL INDEX KEY: 0001575028 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36304 FILM NUMBER: 17573165 MAIL ADDRESS: STREET 1: 1500 WEST PARK DRIVE, SUITE 210 CITY: WESTBOROUGH STATE: MA ZIP: 01581 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-02-01 0 0001533040 RXi Pharmaceuticals Corp RXII 0001575028 Dorman H. Paul C/O RXI PHARMACEUTICALS CORPORATION 257 SIMARANO DRIVE, SUITE 101 MARLBOROUGH MA 01752 1 0 0 0 Stock option (right to buy) 0.629 2017-02-01 4 A 0 2000 0.00 A 2027-02-01 Common Stock 2000 2000 D The stock option vests in equal quarterly installments over one year beginning on the first quarterly anniversary of the grant date. Caitlin Kontulis, attorney-in-fact 2017-02-03